Dopamine Agonists and Pathologic Behaviors
The dopamine agonists ropinirole and pramipexole exhibit highly specific affinity for the cerebral dopamine D3 receptor. Use of these medications in Parkinson’s disease has been complicated by the emergence of pathologic behavioral patterns such as hypersexuality, pathologic gambling, excessive hobb...
Saved in:
Main Authors: | Brendan J. Kelley, Andrew P. Duker, Peter Chiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2012/603631 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dopamine agonists for restless legs syndrome
by: Pran Phakdeekitcharoen, et al.
Published: (2025-02-01) -
Compulsive Drumming Induced by Dopamine Agonists in Parkinson’s Disease: Another Aspect of Punding
by: Carmine Vitale, et al.
Published: (2013-01-01) -
Biological mechanisms of dopamine D2-like receptor agonist therapy in diabetes
by: Zachary Freyberg, et al.
Published: (2025-01-01) -
Prolactin-Secreting Leiomyoma Causing Hyperprolactinaemia Unresponsive to Dopamine Agonist Therapy and Resolution following Myomectomy
by: Lucinda Barry, et al.
Published: (2021-01-01) -
The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
by: Hiroaki Hori, et al.
Published: (2012-01-01)